[Complete and incomplete antibodies in tularemia. I. Immunization with live vaccine]. 1968

V Wagner, and V Patera, and E Sixtová, and V Drnková, and F Major

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008297 Male Males
D003604 Czechoslovakia Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D014406 Tularemia A plague-like disease of rodents, transmissible to man. It is caused by FRANCISELLA TULARENSIS and is characterized by fever, chills, headache, backache, and weakness. Francisella tularensis Infection,Francisella tularensis Infections,Infection, Francisella tularensis,Tularemias
D014612 Vaccines Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases. Vaccine

Related Publications

V Wagner, and V Patera, and E Sixtová, and V Drnková, and F Major
July 1965, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
V Wagner, and V Patera, and E Sixtová, and V Drnková, and F Major
September 1966, Bacteriological reviews,
V Wagner, and V Patera, and E Sixtová, and V Drnková, and F Major
December 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
V Wagner, and V Patera, and E Sixtová, and V Drnková, and F Major
September 1982, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V Wagner, and V Patera, and E Sixtová, and V Drnková, and F Major
September 1978, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V Wagner, and V Patera, and E Sixtová, and V Drnková, and F Major
May 2011, Bulletin of experimental biology and medicine,
V Wagner, and V Patera, and E Sixtová, and V Drnková, and F Major
August 1975, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V Wagner, and V Patera, and E Sixtová, and V Drnková, and F Major
January 1977, The Journal of infectious diseases,
V Wagner, and V Patera, and E Sixtová, and V Drnková, and F Major
September 1996, Mutation research,
V Wagner, and V Patera, and E Sixtová, and V Drnková, and F Major
January 1985, Voprosy onkologii,
Copied contents to your clipboard!